Study Design

Investigator-driven, prospective, randomized, open, blinded outcome assessment (PROBE) parallel-group interventional multi-centre trial.

Left Sidebar

EAST-AFNET 4 an AFNET/EHRA Trial


 


 

News

27.08.2021 | Early rhythm control improves outcomes in patients with asymptomatic atrial fibrillation
Early rhythm control improves outcomes in patients with asymptomatic atrial fibrillation Asymptomatic patients with atrial fibrillation (AF) benefit from early rhythm control therapy comparably to...
25.08.2021 | EAST-AFNET 4 @ ESC Congress 2021
The latest results of the EAST - AFNET 4  study will be presented at this year's ESC congress:
30.07.2021 | Patients with atrial fibrillation and heart failure benefit from early rhythm control
A subgroup analysis of the EAST – AFNET 4 study population revealed: Early initiation of rhythm control therapy is associated with clinical benefit in patients with heart failure and recently...

more NEWS